Dario Amodei said Thursday that Anthropic plans to challenge the Department of Defense’s decision to label the AI firm a supply chain risk in court, a designation he has called “legally unsound.” The ...
Johnson & Johnson JNJ announced that it has submitted a type II variation application to the European Medicines Agency (EMA) seeking approval for the expanded use of Tecvayli (teclistamab). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results